神經病學病患監測市場規模、佔有率和成長分析:按產品類型、疾病類型、最終用戶和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
2036345

神經病學病患監測市場規模、佔有率和成長分析:按產品類型、疾病類型、最終用戶和地區分類-2026-2033年產業預測

Neurology Patient Monitoring Market Size, Share, and Growth Analysis, By Product Type (Magnetic Resonance Imaging (MRI) Devices, Electroencephalography (EEG) Devices), By Disease Type, By End-User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球神經系統病患監測市場價值為 51.1 億美元,預計到 2025 年將成長至 54.7 億美元,到 2033 年將成長至 95 億美元,在預測期(2026-2033 年)內複合年成長率為 7.13%。

全球神經系統病患監測市場專注於創新設備和軟體,用於在各種醫療環境中監測腦部活動、顱內壓、癲癇發作和神經生理訊號。該市場對於早期發現神經系統疾病至關重要,有助於制定決策,從而降低發病率並縮短住院時間。技術進步正推動該領域從間歇性監測轉向整合式多模態平台,這些平台配備人工智慧驅動的分析功能、攜帶式穿戴裝置和雲端共用功能,滿足臨床對連續神經系統數據的需求。關鍵成長要素包括連接性的提升和不斷發展的分析技術,這些技術能夠將原始數據轉化為可操作的臨床見解。此外,用於門診病人癲癇監測的小型穿戴式裝置正在為訂閱服務、不斷發展的報銷模式和新的護理路徑創造機遇,最終改善患者預後,並在市場中創造永續的收入來源。

全球神經病學病患監測市場促進因素

神經系統疾病發病率的不斷上升和病情的日益複雜,凸顯了持續病患監測的迫切需求,促使醫療專業人員和機構尋求創新解決方案,以便早期發現顯著變化並最佳化治療方案調整。持續監測不僅能全面評估症狀和治療效果,還能增強急性和慢性照護中的臨床決策。此外,它還有助於患者更順利地過渡到門診和居家護理。這種向更積極主動的患者管理模式的轉變,推動了對能夠提供持續、長期生理和電生理資訊的高階監測系統的需求。

全球神經病學病患監測市場的限制因素

購置、安裝和維護先進神經監測系統的高昂成本可能會阻礙醫院和診所,尤其是那些資金緊張的機構,採用這些技術。除了高昂的單價外,對專用耗材和專有軟體的需求也增加了整體擁有成本 (TCO),這可能會使醫療機構不願升級過時的系統。此外,預算限制和與其他優先事項的衝突也會延緩採用進程。因此,小規模的醫療機構可能會選擇更經濟實惠的替代方案,進一步阻礙市場成長和先進技術的區域普及,儘管臨床需求仍然存在。

全球神經系統病患監測市場趨勢

全球神經系統疾病病患監測市場正日益受到人工智慧和機器學習技術進步的推動。這些技術能夠更好地解讀連續的神經訊號,從而實現更早期、更準確的診斷。它們有助於檢測細微的模式和具有臨床意義的事件,減輕醫護人員的負擔,並最佳化工作流程的優先順序。整合包括影像、電生理和患者報告結局(PRO)在內的多模態數據,有助於實現個人化治療方案。關於設計和可解釋性的倫理考量日益重要,確保人工智慧能夠作為輔助臨床醫生的工具,從而促進其在各種醫療環境中的普及應用,並簡化醫療流程。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球神經系統病患監測市場規模:依產品類型分類

  • 磁振造影(MRI)設備
    • 功能性磁振造影(fMRI)
    • 閉型
    • 打開
    • 以及可攜式磁振造影系統
  • 腦電圖(EEG)設備
    • 攜帶式腦電圖儀(EEG)
    • 攜帶式臨床腦電圖儀(EEG)
  • 腦氧飽和度監測儀
    • 非侵入式手持系統
  • 顱內壓監測器
    • 侵入式和非侵入式系統
  • 其他

全球神經病學病患監測市場規模:依疾病類型分類

  • 創傷性腦損傷(TBI)
  • 中風
  • 睡眠障礙
  • 帕金森氏症
  • 癲癇
  • 其他

全球神經系統病患監測市場規模:依最終用戶分類

  • 醫院
  • 神經科中心
  • 診斷中心
  • 外科醫療中心和診所

全球神經病學病患監測市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • Medtronic
  • Koninklijke Philips
  • GE HealthCare
  • Nihon Kohden
  • Natus Medical
  • Masimo
  • Abbott
  • Siemens Healthineers
  • Dragerwerk
  • Integra LifeSciences
  • Cadwell Industries
  • Neurosoft
  • BrainScope
  • Advanced Brain Monitoring
  • Compumedics
  • Rimidi
  • Bio-Signal Group
  • Lifelines Neuro
  • Empatica
  • Nuubo

結論與建議

簡介目錄
Product Code: UCMIG35A2620

Global Neurology Patient Monitoring Market size was valued at USD 5.11 Billion in 2024 and is poised to grow from USD 5.47 Billion in 2025 to USD 9.5 Billion by 2033, growing at a CAGR of 7.13% during the forecast period (2026-2033).

The global neurology patient monitoring market focuses on innovative devices and software that monitor brain activity, intracranial pressure, seizure events, and neurophysiological signals in various healthcare environments. This market is crucial for timely detection of neurological issues, influencing decisions that mitigate morbidity and hospital length of stay. Technological advancements have transitioned the field from intermittent testing to integrated multimodal platforms featuring AI-driven analytics, portable wearables, and cloud-sharing capabilities, catering to clinical needs for continuous neurodata. The pivotal growth factors include enhanced connectivity and analytics transforming raw signals into actionable clinical insights. Additionally, miniaturized wearables for outpatient seizure monitoring open up opportunities for subscription services, evolving reimbursement models, and new care pathways, ultimately improving patient outcomes and creating sustainable revenue streams in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurology Patient Monitoring market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurology Patient Monitoring Market Segments Analysis

Global neurology patient monitoring market is segmented by product type, disease type, end-user and region. Based on product type, the market is segmented into Magnetic Resonance Imaging (MRI) Devices, Electroencephalography (EEG) Devices, Cerebral Oximeters, Intracranial Pressure Monitors and Others. Based on disease type, the market is segmented into Traumatic Brain Injury (TBI), Stroke, Sleep Disorders, Parkinson's Disease, Epilepsy and Others. Based on end-user, the market is segmented into Hospitals, Neurology Centers, Diagnostic Centers and Surgical Care Centers and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neurology Patient Monitoring Market

The rising incidence and intricate nature of neurological disorders have amplified the need for ongoing patient monitoring, driving healthcare professionals and facilities to pursue innovative solutions for early detection of critical changes and optimized treatment adjustments. Continuous monitoring not only allows for a comprehensive evaluation of symptoms and therapeutic outcomes but also enhances clinical decision-making in both acute and chronic care scenarios. Moreover, it enables smoother transitions of care into outpatient and home environments. This shift towards a more proactive approach to patient management fosters the demand for advanced monitoring systems capable of delivering consistent long-term physiological and electrophysiological insights.

Restraints in the Global Neurology Patient Monitoring Market

The significant expenses linked to the purchase, installation, and continuous maintenance of sophisticated neurology monitoring systems can inhibit hospitals and clinics, especially those operating under financial constraints, from procuring these technologies. Elevated per unit costs, along with the necessity for specialized consumables and proprietary software, elevate the overall cost of ownership, which may deter healthcare facilities from upgrading older systems. Additionally, budgetary limitations and other competing priorities can lead to delays in the adoption process. Consequently, smaller medical practices may choose more affordable alternatives, further restraining market growth and impeding the regional spread of advanced technologies despite clinical demand.

Market Trends of the Global Neurology Patient Monitoring Market

The Global Neurology Patient Monitoring market is increasingly driven by advancements in AI and machine learning, which enhance the interpretation of continuous neurological signals, leading to earlier and more accurate diagnosis. These technologies facilitate the detection of subtle patterns and clinically relevant events, easing the burden on healthcare professionals and refining workflow prioritization. The integration of multimodal data-including imaging, electrophysiology, and patient-reported outcomes-promotes personalized treatment approaches. Ethical considerations around design and explainability are becoming paramount, ensuring that AI serves as a supportive tool for clinicians, fostering acceptance and streamlining processes across various healthcare settings.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Neurology Patient Monitoring Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Magnetic Resonance Imaging (MRI) Devices
    • Functional MRI (fMRI)
    • Closed
    • Open
    • and Portable MRI Systems
  • Electroencephalography (EEG) Devices
    • Portable and Wireless EEG
    • Ambulatory and Clinical EEG
  • Cerebral Oximeters
    • Non-Invasive and Handheld Systems
  • Intracranial Pressure Monitors
    • Invasive and Non-Invasive Systems
  • Others

Global Neurology Patient Monitoring Market Size by Disease Type & CAGR (2026-2033)

  • Market Overview
  • Traumatic Brain Injury (TBI)
  • Stroke
  • Sleep Disorders
  • Parkinson's Disease
  • Epilepsy
  • Others

Global Neurology Patient Monitoring Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Neurology Centers
  • Diagnostic Centers
  • Surgical Care Centers and Clinics

Global Neurology Patient Monitoring Market Size & CAGR (2026-2033)

  • North America (Product Type, Disease Type, End-User)
    • US
    • Canada
  • Europe (Product Type, Disease Type, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Disease Type, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Disease Type, End-User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Disease Type, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE HealthCare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nihon Kohden
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Natus Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Masimo
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dragerwerk
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cadwell Industries
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurosoft
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BrainScope
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Brain Monitoring
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Compumedics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rimidi
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Signal Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifelines Neuro
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Empatica
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nuubo
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations